Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Siga Technologies Inc (SIGA)

Siga Technologies Inc (SIGA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

SIGA : 6.45 (-0.31%)
Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced

SIGA : 6.45 (-0.31%)
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks

Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.

SIGA : 6.45 (-0.31%)
EBS : 11.66 (+1.57%)
GOVX : 2.07 (-3.27%)
CMRX : 3.96 (+3.39%)
SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024

SIGA : 6.45 (-0.31%)
SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

SIGA : 6.45 (-0.31%)
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

SIGA : 6.45 (-0.31%)
SIGA Announces Agreement to Supply TPOXX® in Morocco

SIGA : 6.45 (-0.31%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END

BCRX : 7.64 (-1.16%)
NNVC : 1.1100 (-0.89%)
VERU : 1.2100 (-5.47%)
CMRX : 3.96 (+3.39%)
SIGA : 6.45 (-0.31%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

NNVC : 1.1100 (-0.89%)
VERU : 1.2100 (-5.47%)
CMRX : 3.96 (+3.39%)
SIGA : 6.45 (-0.31%)
S&P Futures Climb Ahead of Key U.S. Inflation Data, Intel Surges on Upbeat Earnings

September S&P 500 futures (ESU23) are trending up +0.46% this morning as market participants braced for a reading on the Federal Reserve’s preferred inflation gauge.

ESU23 : 4,491.72s (-0.32%)
INTC : 20.83 (-3.43%)
META : 647.49 (+1.73%)
ABBV : 170.30 (-0.22%)
EBAY : 64.81 (+0.09%)
CMG : 56.70 (-1.49%)
XOM : 108.66 (-1.35%)
PG : 164.12 (-1.22%)
AON : 369.16 (+1.23%)
CL : 87.88 (-0.03%)
STAN.L.EB : 1,073.500 (-0.95%)
IAG.L.IX : 327.700 (-1.32%)

Barchart Exclusives

Analysts Predict 1,250% Upside for This ‘Strong Buy’ Quantum Computing Stock in 2025... But Investors Should Stay Away
Zapata Computing has ties to the red-hot quantum computing market but don't be fooled. Its business ceased operations last year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar